A growing set of evidence suggests that using semaglutide could lead to decreased substance use, and a large new study shows a promising link between the medication and tobacco use
On the NHS, Wegovy is typically prescribed within specialist weight management services according to NICE guidance (TA875), which has stricter eligibility criteria than the marketing authorisation (for most adults, BMI 35 kg/m with a weight-related comorbidity, with adjustments for certain groups)
However, separating niacinamide effects from general adaptation to semaglutide is virtually impossible without a controlled comparison
We handle every bureaucratic element, streamlining the prior authorization process and providing support through our prior authorization help team
And I have it in an envelope now
Marketing campaigns emphasized weight loss success while minimizing or failing to mention life-altering complications